Literature DB >> 11926362

A high-throughput HERG potassium channel function assay: an old assay with a new look.

Charles S Cheng1, Dawn Alderman, Jennifer Kwash, John Dessaint, Rita Patel, Mary Kay Lescoe, Michele Bennett Kinrade, Weifeng Yu.   

Abstract

In this paper, we describe an assay using radioactive rubidium (86Rb) efflux to screen functional human ether-a go-go-related gene (HERG) K+ channels in a high-throughput screening (HTS) format. This assay offers an alternative way to examine junctional interactions between chemical compounds and HERG K+ channels. Follow-up experiments and discussions were carried out to address a variety of factors that affect potency evaluation within the Rb efflux assay. Factors that can affect the assay results, such as assay time, efflux rate, and compound blocking kinetics, are discussed in detail. Our results provide some explanations for the variances of the assay results and offer some guidelines for using the Rb efflux assay to evaluate compound interactions with HERG K+ channels in the pharmaceutical industry.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11926362     DOI: 10.1081/ddc-120002451

Source DB:  PubMed          Journal:  Drug Dev Ind Pharm        ISSN: 0363-9045            Impact factor:   3.225


  14 in total

1.  Function recovery after chemobleaching (FRAC): evidence for activity silent membrane receptors on cell surface.

Authors:  Haiyan Sun; Sojin Shikano; Qiaojie Xiong; Min Li
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-17       Impact factor: 11.205

2.  A fluorescent screening assay for identifying modulators of GIRK channels.

Authors:  Maribel Vazquez; Charity A Dunn; Kenneth B Walsh
Journal:  J Vis Exp       Date:  2012-04-24       Impact factor: 1.355

3.  Investigation of miscellaneous hERG inhibition in large diverse compound collection using automated patch-clamp assay.

Authors:  Hai-bo Yu; Bei-yan Zou; Xiao-liang Wang; Min Li
Journal:  Acta Pharmacol Sin       Date:  2016-01       Impact factor: 6.150

Review 4.  The High Cost of Stroke and Stroke Cytoprotection Research.

Authors:  Paul A Lapchak; John H Zhang
Journal:  Transl Stroke Res       Date:  2016-12-30       Impact factor: 6.829

5.  Cardiac Arrhythmia: In vivo screening in the zebrafish to overcome complexity in drug discovery.

Authors:  Calum A Macrae
Journal:  Expert Opin Drug Discov       Date:  2010-07       Impact factor: 6.098

6.  Microfluidic cell culture and its application in high-throughput drug screening: cardiotoxicity assay for hERG channels.

Authors:  Xiaojing Su; Edmond W K Young; Heather A S Underkofler; Timothy J Kamp; Craig T January; David J Beebe
Journal:  J Biomol Screen       Date:  2010-12-03

7.  Identification of human Ether-à-go-go related gene modulators by three screening platforms in an academic drug-discovery setting.

Authors:  Xi-Ping Huang; Thomas Mangano; Sandy Hufeisen; Vincent Setola; Bryan L Roth
Journal:  Assay Drug Dev Technol       Date:  2010-12       Impact factor: 1.738

Review 8.  Drug-induced torsades de pointes and implications for drug development.

Authors:  Robert R Fenichel; Marek Malik; Charles Antzelevitch; Michael Sanguinetti; Dan M Roden; Silvia G Priori; Jeremy N Ruskin; Raymond J Lipicky; Louis R Cantilena
Journal:  J Cardiovasc Electrophysiol       Date:  2004-04

9.  A new homogeneous high-throughput screening assay for profiling compound activity on the human ether-a-go-go-related gene channel.

Authors:  Steven A Titus; Daniel Beacham; Sampada A Shahane; Noel Southall; Menghang Xia; Ruili Huang; Elizabeth Hooten; Yong Zhao; Louie Shou; Christopher P Austin; Wei Zheng
Journal:  Anal Biochem       Date:  2009-07-05       Impact factor: 3.365

10.  Understanding hERG inhibition with QSAR models based on a one-dimensional molecular representation.

Authors:  David J Diller; Doug W Hobbs
Journal:  J Comput Aided Mol Des       Date:  2007-06-05       Impact factor: 4.179

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.